Make an application

cancer research scientist in laboratory

Funding Rounds 2016-2017

There are two rounds of applications in each year, with submissions accepted in April and October. The dates of the next two funding rounds are below:


April 2016 Round

October 2016 Round

Opening date 4th March 2016 1st September 2016
Submissions open 1st April 2016 1st October 2016
Closing date 29th April 2016 28th October 2016
Committee meeting September March
Applicants told results October April
Funding Commences From 1st January 2017 From 1st June 2017

How to register

Our online grant application system requires prior registration and approval of participants before applications can be accepted.

Applicants can register on the Worldwide Cancer Research online application system here.

Please note:

  • Registration can be performed at any time throughout the year.
  • When registering, please do not use BLOCK CAPITAL letters for name, institution and/or country of applicants and participants.
  • All application participants must use their personal institutional email addresses (not commercial webmail accounts such as gmail, yahoo, hotmail etc.).
  • If your institution is not already registered on our database please contact us (grants@worldwidecancerresearch.org) in advance of your personal registration so that we can add your institution to our system.

Along with the main applicant, all other application participants (including Head of Department, Authorising Officer and Co-Applicants) must also register on the Worldwide Cancer Research online application system. Main applicants must check that all application participants have registered on our database prior to completing an application. Please note: it will be useful for the applicant to know the exact format (spelling, accent marks and diacritics) and email address that the participant has used when entering their details on the system.

How to apply

Completing your application

Before applying, please see What to consider before applying and read all information provided in our application handbook. Applications which do not meet the conditions laid down in the application handbook will be rejected.

Applicants can begin composing an application online one month prior to the grant round submission periods which are shown in the table at the top of the page. Detailed instructions for the completion of the online application form can be found in Section 6 of the application handbook. Please be sure to have these instructions to hand while completing the application.

To make an application, please continue to the online application system.

Submitting your application

Applications must be submitted during the submission period open and closing dates which are outlined in the table at the top of this page.

Please note: after the application has been submitted by the applicant, both the Head of Department and Authorising Officer need to approve the submission (one after the other, in that order) before the application is received by Worldwide Cancer Research.  Both approvals must be done before the submission deadline.

The submission of a grant application to Worldwide Cancer Research will be taken as a declaration that all our instructions and advice documents have been complied with and that the applicant and the host institution agree with all of our terms and conditions. The current version of the Worldwide Cancer Research award agreement is included in the application handbook and this should be brought to the attention of the relevant departments at your institution before an application is submitted.

What happens next?

For a summary of what happens following an application submission to Worldwide Cancer Research please see our Application handling procedure page.

Cathy Tournier 200 X 200

Turning the tables on cancer hijackers

How are cells of the immune system hijacked by cancer and how to block this.

Find out more
Paul Teesdale Spittle 200 X 200

Sea sponges to the rescue!

Investigating whether a chemical from special sea sponges holds the secret to killing cancer.

Find out more
Fernando Pastor 200 X 200

Improving Ipilimumab for melanoma patients

Ipilimumab was the first immunotherapy treatment approved by the FDA but can we now make it even more successful?

Find out more

Make a world of difference

Donate with text - it takes less than 30 seconds. Text WORLDWIDE to 70004 to donate £10.

Or Donate Online Now

We have funded 1,776 research projects in 34 countries.

whatever it takes,
wherever it takes us.

Find Out More